SI-BONE INC (SIBN) Stock Price & Overview
NASDAQ:SIBN • US8257041090
Current stock price
The current stock price of SIBN is 14.43 USD. Today SIBN is up by 3.07%. In the past month the price increased by 12.12%. In the past year, price increased by 4.19%.
SIBN Key Statistics
- Market Cap
- 637.373M
- P/E
- N/A
- Fwd P/E
- N/A
- EPS (TTM)
- -0.44
- Dividend Yield
- N/A
SIBN Stock Performance
SIBN Stock Chart
SIBN Technical Analysis
ChartMill assigns a technical rating of 1 / 10 to SIBN. When comparing the yearly performance of all stocks, SIBN is a bad performer in the overall market: 77.32% of all stocks are doing better.
SIBN Fundamental Analysis
ChartMill assigns a fundamental rating of 4 / 10 to SIBN. While SIBN seems to be doing ok healthwise, there are quite some concerns on its profitability.
SIBN Earnings
On February 23, 2026 SIBN reported an EPS of -0.04 and a revenue of 56.35M. The company beat EPS expectations (68.88% surprise) and missed revenue expectations (-1.23% surprise).
SIBN Forecast & Estimates
15 analysts have analysed SIBN and the average price target is 25.65 USD. This implies a price increase of 77.73% is expected in the next year compared to the current price of 14.43.
For the next year, analysts expect an EPS growth of -19.72% and a revenue growth 14.91% for SIBN
SIBN Groups
Sector & Classification
SIBN Financial Highlights
Over the last trailing twelve months SIBN reported a non-GAAP Earnings per Share(EPS) of -0.44. The EPS increased by 42.11% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -7.92% | ||
| ROE | -10.65% | ||
| Debt/Equity | 0.2 |
SIBN Ownership
SIBN Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 17.72 | 174.966B | ||
| ISRG | INTUITIVE SURGICAL INC | 45.72 | 163.009B | ||
| SYK | STRYKER CORP | 22.87 | 132.986B | ||
| BSX | BOSTON SCIENTIFIC CORP | 18.3 | 93.897B | ||
| IDXX | IDEXX LABORATORIES INC | 39.44 | 45.587B | ||
| EW | EDWARDS LIFESCIENCES CORP | 25.96 | 45.039B | ||
| BDX | BECTON DICKINSON AND CO | 11.41 | 44.257B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 14.45 | 33.688B | ||
| RMD | RESMED INC | 18.79 | 33.544B | ||
| DXCM | DEXCOM INC | 24.75 | 24.292B | ||
| ZBH | ZIMMER BIOMET HOLDINGS INC | 11.38 | 18.455B | ||
| HOLX | HOLOGIC INC | 15.48 | 16.969B | ||
| PODD | INSULET CORP | 31.08 | 13.926B |
Related stock screener links
View all stocks in the Health Care Equipment Industry | View all stocks in the Health Care Sector | View all stocks on the Nasdaq Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About SIBN
Company Profile
SI-BONE, Inc. is a medical device company, which engages in the provision of a proprietary minimally invasive surgical implant system to fuse the sacroiliac joint for treatment of musculoskeletal disorders of the sacropelvic anatomy. The company is headquartered in Santa Clara, California and currently employs 376 full-time employees. The company went IPO on 2018-10-17. The firm specializes in minimally invasive surgical implant systems to address sacroiliac joint dysfunction as well as address unmet clinical needs in pelvic fixation and management of pelvic fractures. The firm's products include a series of patented titanium implants, and the instruments used to implant them, as well as implantable bone products. Its products include iFuse, iFuse-3D, iFuse-TORQ and iFuse Bedrock Granite. Within the United States, iFuse, iFuse-3D and iFuse-TORQ have clearances for applications across sacroiliac joint dysfunction and fusion, adult spinal deformity and degeneration, and pelvic trauma. Its first-generation iFuse, a machined triangular titanium implant, has a triangular cross section that resists twisting or rotation of the implant. The firm's second generation iFuse product, the iFuse-3D implant, is a patented titanium implant.
Company Info
IPO: 2018-10-17
SI-BONE INC
471 El Camino Real, Suite 101
Santa Clara CALIFORNIA 95050 US
CEO: Jeffrey W. Dunn
Employees: 376
Phone: 14082070700
SI-BONE INC / SIBN FAQ
What does SIBN do?
SI-BONE, Inc. is a medical device company, which engages in the provision of a proprietary minimally invasive surgical implant system to fuse the sacroiliac joint for treatment of musculoskeletal disorders of the sacropelvic anatomy. The company is headquartered in Santa Clara, California and currently employs 376 full-time employees. The company went IPO on 2018-10-17. The firm specializes in minimally invasive surgical implant systems to address sacroiliac joint dysfunction as well as address unmet clinical needs in pelvic fixation and management of pelvic fractures. The firm's products include a series of patented titanium implants, and the instruments used to implant them, as well as implantable bone products. Its products include iFuse, iFuse-3D, iFuse-TORQ and iFuse Bedrock Granite. Within the United States, iFuse, iFuse-3D and iFuse-TORQ have clearances for applications across sacroiliac joint dysfunction and fusion, adult spinal deformity and degeneration, and pelvic trauma. Its first-generation iFuse, a machined triangular titanium implant, has a triangular cross section that resists twisting or rotation of the implant. The firm's second generation iFuse product, the iFuse-3D implant, is a patented titanium implant.
Can you provide the latest stock price for SI-BONE INC?
The current stock price of SIBN is 14.43 USD. The price increased by 3.07% in the last trading session.
What is the dividend status of SI-BONE INC?
SIBN does not pay a dividend.
How is the ChartMill rating for SI-BONE INC?
SIBN has a ChartMill Technical rating of 1 out of 10 and a ChartMill Fundamental rating of 4 out of 10.
How is the valuation of SI-BONE INC (SIBN) based on its PE ratio?
SI-BONE INC (SIBN) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.44).
Can you provide the number of employees for SI-BONE INC?
SI-BONE INC (SIBN) currently has 376 employees.
What is the market capitalization of SIBN stock?
SI-BONE INC (SIBN) has a market capitalization of 637.37M USD. This makes SIBN a Small Cap stock.